Aurinia Pharmaceuticals (AUPH) PT Raised to $12 at HC Wainwright; 'R&D Day Showcases New Indications ... - StreetInsider.com

Aurinia Pharmaceuticals (AUPH) PT Raised to $12 at HC Wainwright; 'R&D Day Showcases New Indications ...
StreetInsider.com
H.C. Wainwright raised its price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $12.00 (from $10.00) while maintaining a Buy rating, following the company's announcement to to expand voclosporin development to include focal segmental ...